Tag Archives: Phase II

Roche’s Fenebrutinib Demonstrates Promising Results with Low Relapse Rates and No Disability Progression in Phase II Multiple Sclerosis Study

(IN BRIEF) Roche presented promising 96-week data from the Phase II FENopta study, showing that its investigational drug, fenebrutinib, significantly reduced relapse rates and prevented disability progression in patients with relapsing multiple sclerosis (RMS). The study revealed an annualized relapse … Read the full press release

EIB Grants €4.7 Million for Hrybovychi Landfill Reclamation Project in Lviv

(IN BRIEF) The European Investment Bank (EIB) has granted a €4.7 million EU-backed loan to support the reclamation of the Hrybovychi landfill in Lviv, Ukraine. This funding will help improve waste management infrastructure, address environmental hazards, and transform the landfill … Read the full press release

GSK’s mRNA Flu Vaccine Candidate Moves to Phase III After Positive Phase II Results

(IN BRIEF) GSK has reported positive results from its phase II trial for an mRNA seasonal influenza vaccine candidate, showing strong immune responses against influenza A and B strains in both younger and older adults. The trial met success criteria … Read the full press release